# Grace Therapeutics, Inc.: Form 20-F for the period ended Mar 31, 2017

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 20-F
- Filed: 2017-06-27
- Accepted by EDGAR: Jun 27, 2017, 17:24 ET
- Period: 2017-03-31
- Accession: 0001193125-17-215074
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000119312517215074/d416340d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000119312517215074/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000119312517215074/d416340d20f.htm

Filed Jun 27, 2017.
Source: SEC EDGAR, the filing index for accession 0001193125-17-215074. Last ingested by Listed: Nov 14, 2026, 23:10 ET. No prices; not investment advice.
